References
- Mitchell TG, Perfect JR. Cryptococcosis in the era of AIDS-100 years after the discovery of cryptococcus neoformans. Clin Microbiol Rev 1995;8:515–548.
- Perfect JR, Dismukes WE, Dromer F, . Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis 2010;50:291–322.
- Pappas PG, Perfect JR, Cloud JA, . Cryptococcosis in human immunodeficiency virus-negative patients in the era of effective azole therapy. Clin Infect Dis 2001;33:690–699.
- Sun HY, Alexander BD, Lortholary O, . Unrecognized pretransplant and donor-derived cryptococcal disease in organ transplant recipients. Clin Infect Dis 2010;51:1062–1069.
- Hallek M, Fischer K, Fingerle-Rowson G, . Addition of rituximab to fludarabine and cyclophosphamide in patients with chronic lymphocytic leukaemia: a randomised, open-label, phase 3 trial. Lancet 2010;376:1164–1174.
- Leenders A, Sonneveld P, De Marie S. Cryptococcal meningitis following fludarabine treatment for chronic lymphocytic leukemia. Eur J Clin Microbiol Infect Dis 1995;14:826–828.
- Costa P, Luzzati R, Nicolato A, . Cryptococcal meningitis and intracranial tuberculoma in a patient with Waldenstrom's macroglobulinemia treated with fludarabine. Leuk Lymphoma 1998; 28:617–620.
- Chim CS, Liang R, Wong SSY, . Cryptococcal infection associated with fludarabine therapy. Am J Med 2000;108:523–524.
- Benetatos M, Hatzimichael E, Vassou A, . Cryptococcus lung infection complicating fludarabine treatment in a chronic lymphocytic leukemia patient. Leuk Res 2007;31:119–120.
- Assing K, Birgens H, Arendrup M. Cryptococcus neoformans var. neoformans resistant to fluconazole in an HIV-negative patient with chronic lymphocytic leukemia. Clin Microbiol Infect 2003;9: 441–444.
- Reisfeld-Zadok S, Elis A, Szyper-Kravitz M, . Cryptococcal meningitis in chronic lymphocytic leukemia patients. Isr Med Assoc J 2009;11:437–439.
- Ahmed I, Powell S, Hoth M, . Cryptococcal meningitis presenting with recurrent syncope in a patient with chronic lymphoid leukemia: a case report. Cases J 2009;2:103.
- Hachem R, Hanna H, Kontoyannis D, . The changing epidemiology of invasive candidiasis: Candida glabrata and Candida krusei as the leading causes of candidemia in hematologic malignancy. Cancer 2008;112:2493–2499.
- Horn DL, Neofytos D, Anaissie EJ, . Epidemiology and outcomes of candidemia in 2019 patients: data from the prospective antifungal therapy alliance registry. Clin Infect Dis 2009;48: 1695–1703.
- Mann PA, McNicholas PM, Chau AS, . Impact of antifungal prophylaxis on colonization and azole susceptibility of candida species. Antimicrob Agents Chemother 2009;53:5026–5034.